Performance of a vancomycin dosage regimen developed for obese patients-Reference-Cited by-同舟云学术

Performance of a vancomycin dosage regimen developed for obese patients

Published:2012-06-01 Issue:11 Volume:69 Page:944-950
ISSN:1079-2082
Container-title:American Journal of Health-System Pharmacy
language:en
Short-container-title:

Author:

Reynolds David C.¹,Waite Laura H.²,Alexander Donald P.³,DeRyke C. Andrew⁴

Affiliation:

1. Moses H. Cone Memorial Hospital, Greensboro, NC; when this article was written, he was Clinical Staff Pharmacist, Department of Pharmacy, Orlando Health, Orlando, FL

2. Department of Pharmacy, Orlando Health, Orlando, FL

3. Infectious Diseases, Department of Pharmacy, University of Utah Hospitals and Clinics, Salt Lake City

4. Optimer Pharmaceuticals, Altamonte Springs, FL; at the time of writing, he was Infectious Diseases Clinical Specialist, Department of Pharmacy, Division of Infectious Diseases, Orlando Health

Publisher

Oxford University Press (OUP)

Subject

Health Policy,Pharmacology

Link

http://academic.oup.com/ajhp/article-pdf/69/11/944/28455017/ajhp0944.pdf

Reference24 articles.

1. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists;Rybak;Am J Health-Syst Pharm.,2009

2. Vancomycin dosing in morbidly obese patients;Bauer;Eur J Clin Pharmacol.,1998

3. Vancomycin pharmacokinetics in normal and morbidly obese subjects;Blouin;Antimicrob Agents Chemother.,1982

4. Effect of obesity on vancomycin pharmacokinetic parameters as determined by using a Bayesian forecasting technique;Vance-Bryan;Antimicrob Agents Chemother.,1993

5. Determining vancomycin clearance in an overweight and obese population;Leong;Am J Health-Syst Pharm.,2011

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is It Still Beneficial to Monitor the Trough Concentration of Vancomycin? A Quantitative Meta-Analysis of Nephrotoxicity and Efficacy;Antibiotics;2024-05-28

2. Therapeutic Drug Monitoring of Antimicrobials in Critically Ill Obese Patients;Antibiotics;2023-06-24

3. Dose optimization of vancomycin in obese patients: A systematic review;Frontiers in Pharmacology;2023-03-24

4. Vancomycin dosing in patients with obesity;American Journal of Health-System Pharmacy;2022-08-18

5. Vancomycin dosing in an obese patient with acute renal failure: A case report and review of literature;World Journal of Clinical Cases;2022-06-26